Has Tadeh Setaghian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,819 in general payments to Tadeh Setaghian, MD across 205 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tadeh Setaghian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tadeh Setaghian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tadeh Setaghian, MD

Pain Medicine · Lawndale, CANPI 1083076376

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,686 of the $8,819 with a category attached, or 75.8%. 16 manufacturers reported payments, led by Medtronic at 42.9% of the total. Reporting peaked in 2023 at $3,782 and has fallen 70.6% since, to $1,113 in 2025.

$8,819in general payments, 2019–2025

Across 205 payments — averaging $43.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$4K
Boston Scientific$3K
Spinal Simplicity, LLC$1K
Nalu Medical, Inc.$206
Nevro Corp.$171
Biotronik NRO, Inc.$88
plus $418 from 10 others

$410in research payments, 2019–2025

Across 1 payment — averaging $410.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$410

What the payments were for

Travel & lodging$2,13424%
Food & beverage$6,68676%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	116	$3,788
Boston Scientific	51	$3,028
Spinal Simplicity, LLC	6	$1,121
Nalu Medical, Inc.	9	$206
Nevro Corp.	2	$171
Biotronik NRO, Inc.	4	$88
Curonix LLC	5	$82
Pfizer	2	$63
SPR Therapeutics, Inc	2	$52
Abbott	1	$52
Scilex Pharmaceuticals Inc.	2	$38
Globus Medical	1	$32
Biohaven Pharmaceutical Holding Company Ltd.	1	$28
Si-bone, Inc.	1	$26
Pacira Pharmaceuticals Incorporated	1	$23
Valinor Pharma, LLC	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Superion Indirect Decompression System$1,065
HA MINUTEMAN G3-R$1,059
WaveWriter Alpha Prime 16$255
RESTORE$170
Omnia$121
GENERAL PAIN MANAGEMENT$120
INTELLIS ADAPTIVESTIM$118
INTELLIS$108
SUPERION$106
VANTA ADAPTIVESTIM$105

How this compares

$8,819 in reported general payments places this provider in the 80th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$102,792

Medicare patients

114

Services billed

5,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	395	$9,561
Zolmitriptan	11	$5,569
Pregabalin	56	$2,187
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	95	$1,959
Fentanyl	24	$1,699
Naloxone Hcl	31	$1,466
Gabapentin	137	$1,362
Tizanidine Hcl	76	$753
Cyclobenzaprine Hcl	122	$664
Lidocaine	13	$569
Tramadol Hcl	96	$504
Morphine Sulfate ErMorphine Sulfate	21	$442
Methadone Hcl	24	$312
Acetaminophen-CodeineAcetaminophen With Codeine	19	$282
Diclofenac Sodium	31	$256

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lawndale

Rostam KhoshsarLawndale$32K
Jason PopeSanta Rosa$2.1M
Ramana NaiduLarkspur$1.4M
Foead GeulaStudio City$1.3M
Krishnan ChakravarthyTemecula$1.3M
Kasra AmirdelfanWalnut Creek$783K
Eric GrigsbyNapa$499K
Jacqueline WeisbeinNapa$494K
Gerald SacksSanta Monica$389K
Samir ShethRoseville$356K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →